Identification of di(β-phenylisopropyl)amine as the main ingredient in illicit amphetamine tablets

Annali dell'Istituto Superiore di Sanita

Volumn 38, Issue 3, 2002, Pages 331-335

  Ottaviano, Valeria ^a   Furnari, Carmelo ^a   Rosati, Felice ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Amphetamines; Designer drugs; di( phenylisopropyl)amine; GC MS; NMR

Indexed keywords

AMPHETAMINE; BIS(ALPHA METHYLPHENETHYL)AMINE; CAFFEINE; DESIGNER DRUG; ILLICIT DRUG; PROPYLAMINE; UNCLASSIFIED DRUG;

CHEMICAL STRUCTURE; CHROMATOGRAPHY; CONFERENCE PAPER; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRAFFIC; DRUG TRANSFORMATION; GAS CHROMATOGRAPHY; ITALY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TABLET; ULTRAVIOLET SPECTROSCOPY;

AMPHETAMINES; STREET DRUGS; TABLETS;

EID: 0036958698     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Schiavone S. Il mercato illecito delle sostanze stupefacenti in Italia: nuove droghe e trend di sviluppo. In: Laviola G, Saso L, Azzaro Pulvirenti R, Silvestrini B (Ed.). Aspetti etici, mentali, sperimentali e giuridici coinvolti nel fenomeno droga. Ann 1st Super Sanità 2002;38:315-8.
2. Furnari C, Ottaviano V, Rosati F, Tondi V. Identification of 3,4-methylenedioxyamphetamine analogs encountered in clandestine tablets. For Sci Int 1998;92:49-58.
3. Moffat AC. Thin-layer chromatography. In: Moffat AC, Jackson JV, Moss MS, Widdop B (Ed.). Clarke's isolation and identification of drugs in pharmaceuticals, body fluids, and post-mortem material. 2nd ed. London: The Pharmaceutical Press; 1986. p. 168-9.
4. Ketema H, Davis WM et al. Pharmacologic and toxicologic effects of di(beta-phenylisopropyl)amine (DPIA) in rats and mice. Gen Pharmacol 1990;21(5):783-90.
5. Weibel PA, Hesse M. Helv Chim Acta 1973;56(7):2460-79.
6. Gohlke RS, McLafferty FW. Anal Chem 1962;34(10):1281-7.
7. Silverstein RM, Webster FX. Spectrometric identification of organic compounds. 6th ed. John Wiley & Sons, Inc; 1997. p. 170-2.
8. Kram TC. Reidentification of a major impurity in illicit amphetamine. J Forensic Sci 1979;24(3):596-9.
9. Sanger DG, Humphreys IJ, Patel AC, Japp M, Osborne RGL. The significance of gas chromatographic impurity patterns obtained from illicitly produced amphetamine. For Sci Int 1985;28:7-17.
10. Moore KA, Soine WH, Poklis A. α-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis. I. Physical characterization and GC-MS analysis of BNMPA and anticipated metabolites in urine. J Anal Toxicol 1995;19:542-48.
11. Moore KA, Poklis A. α-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis. II. Metabolism and urinary excretion (human). J Anal Toxicol 1995;19:549-53.